Issues & Trends

FINO INC. Announces 15 Billion Won Rights Offering for CosmoAM&T… "To Strengthen Competitiveness in the Rechargeable Battery Materials Business"

Park Jung-Soo
2026-08-31 08:49:09
[Edaily Reporter Park Jung-Soo ] Skymoons Technology, Inc.(033790), a company specializing in rechargeable battery materials, announced on the 31st that it held a board of directors meeting and decided to conduct a 15 billion won third-party private placement targeting CosmoAM&T. The scheduled payment date is September 7.
Through this capital increase, FINO INC. plans to secure funds to expand its rechargeable battery materials business. CosmoAM&T is a company specializing in rechargeable battery materials that produces cathode active materials for rechargeable batteries.
FINO INC. is expanding its business scope based on its nickel-cobalt-manganese (NCM) precursor business and has recently broadened its business portfolio to include lithium iron phosphate (LFP) cathode materials. The company is working to strengthen its competitiveness in the rechargeable battery materials business, including the construction of an LFP cathode material production base in Pohang, North Gyeongsang Province, through its subsidiary, C&P New Materials Technology.
A company official stated, “We plan to secure funds for the expansion of our rechargeable battery materials business through this rights offering,” adding, “We will do our utmost to enhance shareholder value by strengthening our business competitiveness and achieving sustained earnings growth.”

Economy

Corporation

IT·Science

Economy

[Market Insight] Interest Rates or Flexibility… U.S. Companies Weigh Private Placement Loans and Syndicated Loans

As the syndicated loan market regains momentum, U.S. companies are crunching the numbers on their financing options. While some companies are switching from private loans to syndicated loans in an eff…
2026-10-22 18:04:05

Corporation

Dicigen’s Next-Generation Breast Cancer Prognosis Prediction Kit Passes New Medical Technology Evaluation… Expected to Generate Over 10 Billion Next Year

D-Cigen, a company specializing in precision medicine and genetic diagnostics, is set to begin full-scale distribution in South Korea of “OncoFREE,” a next-generation sequencing (NGS)-based multi-gene…
2026-10-23 07:06:03

IT·Science

Jugaije, Establishing a Korean Subsidiary: Partnership with JW on Hemlibra Continues... Will It Develop New Drugs Independently?

(Graphic: ChatGPT) Japanese pharmaceutical company Chugai Pharmaceutical, which is establishing a subsidiary in South Korea, has expanded its options for operating its domestic business. While con…
2026-10-23 07:06:02